Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003–2014

Abdullah, 2016, Use of claims data to estimate annual cervical cancer screening percentages in Portland metropolitan area, Oregon, Cancer Epidemiol., 41, 106, 10.1016/j.canep.2016.01.010 ACOG Committee on Practice Bulletins–Gynecology, 2009, ACOG practice bulletin no. 109: cervical cytology screening, Obstet. Gynecol., 114, 1409, 10.1097/AOG.0b013e3181c6f8a4 American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Gynecology, 2016, ACOG Practice bulletin no. 168: cervical cancer screening and prevention, Obstet. Gynecol., 128, e111, 10.1097/AOG.0000000000001708 American Medical Association, 2014 Beavis, 2017, Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States, Cancer, 123, 1044, 10.1002/cncr.30507 Centers for Disease Control and Prevention, 2017 Centers for Medicare and Medicaid Services Flagg, 2018, Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006–2014, Am. J. Public Health, 108, 112, 10.2105/AJPH.2017.304119 Flagg, 2013, Prevalence of anogenital warts among participants in private health plans in the United States, 2003–2010: potential impact of human papillomavirus vaccination, Am. J. Public Health, 103, 1428, 10.2105/AJPH.2012.301182 Gamble, 2017, Surveillance for certain health behaviors and conditions among states and selected local areas - behavioral risk factor surveillance system, United States, 2013 and 2014. MMWR. Surveillance summaries: morbidity and mortality weekly report, Surveill. Summ./CDC, 66, 1, 10.15585/mmwr.ss6616a1 Guo, 2017, Human papillomavirus vaccination and pap smear uptake among young women in the United States: role of provider and patient, J. Women's Health (Larchmt), 26, 1114, 10.1089/jwh.2017.6424 Healthy People 2020 International Classification of Diseases Kim, 2000, Permutation test for joinpoint regression with applications to cancer rates. Statistics in Medicine 2000; 19; 335-51 (correction: 2001; 20: 655), Stat. Med., 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z Lofters, 2013, Does social disadvantage affect the validity of self-report for cervical cancer screening?, Int. J. Womens Health, 5, 29, 10.2147/IJWH.S39556 National Cancer Institute Qin, 2017, Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation, Cancer Causes Control, 28, 41, 10.1007/s10552-016-0835-1 Rauscher, 2008, Accuracy of self-reported cancer-screening histories: a meta-analysis, Cancer Epidemiol. Biomark. Prev., 17, 748, 10.1158/1055-9965.EPI-07-2629 Tangka, 2015, Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997–2012, Cancer Causes Control, 26, 671, 10.1007/s10552-015-0524-5 U.S. Preventive Services Task Force Watson, 2015, Provider management of equivocal cervical cancer screening results among underserved women, 2009–2011: follow-up of atypical squamous cells of undetermined significance, Cancer Causes Control, 26, 759, 10.1007/s10552-015-0549-9 Watson, 2017, National assessment of HPV and Pap tests: changes in cervical cancer screening, National Health Interview Survey, Prev. Med., 100, 243, 10.1016/j.ypmed.2017.05.004 White, 2017, Cancer screening test use - United States, 2015, MMWR Morb. Mortal. Wkly Rep., 66, 201, 10.15585/mmwr.mm6608a1